Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.
about
Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for EnhancementExpression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cellsA porphobilinogen deaminase (PBGD) Ran-binding protein interaction is implicated in nuclear trafficking of PBGD in differentiating glioma cellsComparison of the photodynamic effect of exogenous photoprotoporphyrin and protoporphyrin IX on PAM 212 murine keratinocytes.Milestones in the development of photodynamic therapy and fluorescence diagnosis.System development for high frequency ultrasound-guided fluorescence quantification of skin layers.Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model.Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.Review of Neurosurgical Fluorescence Imaging Methodologies.Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer.Photodynamic activation as a molecular switch to promote osteoblast cell differentiation via AP-1 activationVitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy.Biomodulatory approaches to photodynamic therapy for solid tumorsVitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors.Prospects for the use of differentiation-modulating agents as adjuvant of photodynamic therapy for proliferative dermatoses.The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy.Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells.Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.Unknown biological effects of L-glucose, ALA, and PUFA.Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.Effects of sodium butyrate on cell death induced by photodynamic therapy in U373-MG and D54-MG astrocytoma cell lines.Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells.Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.Is delta-aminolevulinic acid dehydratase rate limiting in heme biosynthesis following exposure of cells to delta-aminolevulinic acid?5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters.Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.Sequential systemic retinoid and photodynamic therapy for multiple keratotic pigmented nodular basal cell carcinomas on the scalp.Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
P2860
Q26777817-58903D65-6245-480B-81C6-D094D98E7B20Q28204741-2AADA4E1-FCBF-4156-AEF8-7A608B7162D1Q28577898-D66C86F1-C2BA-444C-8D05-C5D3A91C7801Q30872538-CA37C3EC-6F5E-4B31-8BE8-0EFF67B32652Q33307700-C4DAC2DB-C52D-4A0B-A869-4B9A02F5C8ADQ33836259-9025969D-5A88-44D3-AC44-B4445BAEF8D1Q33872581-7CE2A39C-1478-4579-BC41-51642A44E6E0Q33939514-1375EBF3-99BB-4763-85FF-A87CAE201EA6Q33960755-5D90546F-0D42-46C2-BA72-B63294953D5CQ34023717-187F67D3-AA43-4752-96D5-CEFF606FA07EQ35585820-EF3A0B0B-DB23-49DC-99EB-252A9D03E095Q35602107-7626645D-1A1C-4005-A450-66285847D940Q35747537-FD9403B3-2BD5-48C7-A54E-6E48162C0063Q35988610-9F27FF92-EE97-4439-8BE0-99D7BF8B420CQ36271147-99194685-E1AE-4077-8B26-A67A21C56725Q36283013-6984D70F-8598-48D5-9759-905A4B1C7C03Q36477161-FBCC6F76-74E0-4A7D-BE90-85445747F2A0Q36612248-0E53068B-0102-4BCC-8DF1-949028486267Q36983114-53113A7C-00A6-42EB-96ED-363F0AC10733Q37095295-4C855E67-5815-4855-BA8E-3F8634C958FFQ37141274-713438C0-10C4-4D97-92D0-2DA8FA5E60F2Q38221277-F69D5059-3074-44DC-A62C-42545A18C9F8Q38786890-6285AB71-5D5D-48EA-8217-8A01D1F4B7BAQ38799083-CBB9AC04-D37B-4B3C-9F5A-14CA15E34FD0Q39329059-A858BAE9-4BF3-40C6-B3DA-0C713D1EEA67Q39339787-6D0E45E5-AFA9-46BF-8894-7D78A88587B7Q39487686-29F4A0CA-21AE-49D9-B380-9028B7D29A95Q39849618-02DEAC50-F3FB-4A04-A788-1D46798E80B1Q39850358-A7F41C21-5A88-4BF0-BAE8-49D73B73DD42Q39852253-D0D13DF0-CF00-4F68-A770-4534CBF1DE9FQ40109611-B92B41C0-75DB-4A71-A74F-A8B87A40F980Q40685972-02D38942-C59B-4B11-A9E1-98F38101088CQ40815868-FB24E46D-768F-48F7-911D-056EE57EA071Q40878742-3612DE43-494B-4534-81B4-AD4BAC527D19Q42448455-3A25F951-80AF-476C-987C-E558D02408E1Q42459105-31111704-716B-4D7D-A57A-C55C5A6367C6Q42469330-06712CF8-CC42-4BE5-A3DF-EDD7D78CBF99Q46588191-169A353C-C4E2-4E3B-976E-0CBA5D41DAF2
P2860
Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Differentiation-specific incre ...... n primary mouse keratinocytes.
@en
Differentiation-specific incre ...... n primary mouse keratinocytes.
@nl
type
label
Differentiation-specific incre ...... n primary mouse keratinocytes.
@en
Differentiation-specific incre ...... n primary mouse keratinocytes.
@nl
prefLabel
Differentiation-specific incre ...... n primary mouse keratinocytes.
@en
Differentiation-specific incre ...... n primary mouse keratinocytes.
@nl
P2093
P2860
P356
P1476
Differentiation-specific incre ...... n primary mouse keratinocytes.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.292
P407
P577
1998-06-01T00:00:00Z